Financial News
Geron Corp (NQ: GERN )
1.780
USD
-0.080
(-4.30%)
Official Closing Price
Updated: 4:30 PM EST, Mar 2, 2021
Add to My Watchlist
Stories about Geron Corp
From Benzinga
Could Geron Be a Millionaire-Maker Stock?
February 23, 2019
From Motley Fool
Why Geron Stock Briefly Spiked Today
February 13, 2019
From Motley Fool
Benzinga's Top Upgrades, Downgrades For February 13, 2019
February 13, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For January 31, 2019
January 31, 2019
From Benzinga
Why Geron Stock Dropped 44% in 2018
January 15, 2019
From Motley Fool
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
December 20, 2018
From Benzinga
The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
December 19, 2018
From Benzinga
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
December 18, 2018
From Benzinga
Here Are Biotech’s Big Pipeline Disappointments in 2018
December 18, 2018
From Motley Fool
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan
December 18, 2018
From Benzinga
Top 10 Healthcare Stories of 2018
December 13, 2018
From Motley Fool
The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings
December 11, 2018
From Benzinga
The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs
December 02, 2018
From Benzinga
How Geron's Horrible Year Is a Great Reminder to Investors
November 02, 2018
From Motley Fool
Scary Markets, Frightening Stocks, and How to Keep From Panicking
November 01, 2018
From Motley Fool
Why Geron Corporation Stock Is Ripping Higher Today
November 01, 2018
From Motley Fool
The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal
November 01, 2018
From Benzinga
Here's Why Geron Plummeted 69% in September
October 09, 2018
From Motley Fool
Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?
October 08, 2018
A partner walks away and trial data fails to impress. Here's what's next for these biotech upstarts.
From Motley Fool
Geron Stock: Buy, Sell, or Hold?
October 08, 2018
From Motley Fool
46 Biggest Movers From Friday
September 30, 2018
From Benzinga
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs
September 30, 2018
From Benzinga
Benzinga's Bulls & Bears Of The Week: Apple, GE, IBM, Nike, Tesla And More
September 30, 2018
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
